enow.com Web Search

  1. Ad

    related to: revlimid approved indications

Search results

  1. Results from the WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]

  3. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    Lenalidomide is approved in nearly 70 countries, in combination with dexamethasone for the treatment of patients with MM who have received at least one prior therapy. Orphan indications include diffuse large B-cell lymphoma , chronic lymphocytic leukemia and mantle cell lymphoma .

  4. Celgene - Wikipedia

    en.wikipedia.org/wiki/Celgene

    In December 2005, Celgene received approval from the FDA to market Revlimid for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Focalin XR was later launched by Celgene and Novartis in 2005.

  5. Revlimid Gains, Celgene Loses - AOL

    www.aol.com/news/2013-06-05-celgene-gains-new...

    Good newsThe U.S. Food and Drug Administration approved Revlimid as. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...

  6. More Good News for Celgene - AOL

    www.aol.com/news/2013-02-11-more-good-news-for...

    As expected, the U.S. Food and Drug Administration granted approval on Feb. 8 for Celgene's Pomalyst in treating patients with multiple myeloma. Patients must have received at least two prior ...

  7. Celgene and Pharmacyclics Bring Big Change to Mantle Cell ...

    www.aol.com/news/2013-12-13-celgene-and-pharmacy...

    Patients with mantle cell lymphoma got new hope thanks to newly approved treatments in 2013. That's good news for the 2,800 U.S. patients with MCL, a hard-to-treat disease with a significant need ...

  8. Thalidomide - Wikipedia

    en.wikipedia.org/wiki/Thalidomide

    [92] [93] Celgene has sponsored numerous clinical trials with analogues to thalidomide, such as lenalidomide, that are substantially more powerful and have fewer side effects — except for greater myelosuppression. [94] In 2005, Celgene received FDA approval for lenalidomide (Revlimid) as the first commercially useful derivative. Revlimid is ...

  9. Can This Celgene Drug Defy the Patent Cliff? - AOL

    www.aol.com/news/2013-02-11-a-wile-e-coyote-kind...

    I still love Road Runner cartoons. My favorite part as a kid was watching Wile E. Coyote chase after the Road Runner and walk right off a cliff. He'd always walk for several feet before realizing ...

  1. Ad

    related to: revlimid approved indications